FDA chief: Cancer treatment comes with ‘financial toxicity’

Published



The head of the Food and Drug Administration said far too many patients find themselves in “a financial no-man’s land” because of shouldering the costs of cancer medications.

The comments are the latest attack from FDA Commissioner Scott Gottlieb on drug prices and insurers.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.